A bladder preservation regimen using intra-arterial chemotheraphy and radiotheraphy for invasive bladder cancer: A prospective study

International Journal of Urology

Volumn 7, Issue 2, 2000, Pages 41-48

  Miyanaga, Naoto ^a   Akaza, Hideyuki ^a   Okumura, Toshiyuki ^b   Sekido, Noritoshi ^a   Kawai, Koji ^a   Shimazui, Toru ^a   Kikuchi, Koji ^a   Uchida, Katsunori ^a   Takeshima, Hitoshi ^a   Ohara, Kiyoshi ^a   Akine, Yasuyuki ^b   Itai, Yuji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

Author keywords

Bladder neoplasm; Cisplatin; Intra arterial; Methotrexate; Proton; Radiation

Indexed keywords

CISPLATIN; METHOTREXATE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CAPACITY; BLADDER FUNCTION; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; ORGAN PRESERVATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TUMOR BIOPSY; X IRRADIATION;

AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT FAILURE; URINARY BLADDER NEOPLASMS;

EID: 12944250929     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2000.00137.x     Document Type: Article

References (21)

1. Caffo O, Fellin G, Graffer U et al. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. Cancer 1996; 78: 1089-97.
2. Skinner DG, Daniels JR, Russell CA et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J. Urol. 1991; 145: 459-64.
3. Raghaven D, Shipley WU, Garnick MB et al. Biology and management of bladder cancer. N. Engl. J. Med. 1990; 322: 1129-38.
4. Thrasher JB, Crawford ED. Current management of invasive and metastatic transitional cell carcinoma of bladder. J. Urol. 1993; 149: 957-72.
5. Miyanaga A, Akaza H, Ohtani M et al. A bladder-sparing regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer. J. Urol. 1996; 155:664A.
6. Hoshi S, Orikasa S, Yoshikawa K et al. Whole layer needle biopsy for evaluation of neoadjuvant therapy to invasive bladder cancer. Jpn. J. Urol. 1991; 82: 1649-55.
7. Herr HW, Scher HI. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer. J. Clin. Oncol. 1994; 12: 975-80.
8. Srougi M, Simon SD. Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: A 5-year follow up. J. Urol. 1994; 151: 593-7.
9. Kaufman DS, Shipley WU, Griffin PP et al. Selective bladder preservation by combination treatment of invasive bladder cancer. N. Engl. J. Med. 1993; 329: 1377-82.
10. Kachnic LA, Kaufman DS, Heney NM et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J. Clin. Oncol. 1997; 15: 1022-9.
11. Tester W, Porter A, Asbell S et al. Combined modality program with possible organ preservation for invasive bladder carcinoma. Results RTOG Protocol 85-12. Int. J. Radiat. Oncol. Biol. Phys. 1993; 25: 783-90.
12. Tester W, Caplan R, Hesney J et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer. Results of radiation therapy oncology group phase II trial 8802. J. Clin. Oncol. 1996; 14: 119-26.
13. Chauvet B, Brewer Y, Felix-Faure C et al. Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder. Cancer 1993; 72: 2213-18.
14. Dunst J, Sauer R, Schrott KM et al. Organ-sparing treatment of advanced bladder cancer: A 10-year experience. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30: 261-6.
15. Given RW, Parsons JT, McCarley D et al. Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A five-year follow-up. Urology 1995; 46: 499-505.
16. Eapen L, Stewart D, Danjoux C et al. Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer. J. Clin. Oncol. 1989; 7: 230-5.
17. Whitmore Jr WF. Management of invasive bladder neoplasms. Semin. Urol. 1983; 1: 34-41.
18. Miyanaga N, Ami Y, Ohtani M et al. Clinical study with proton radiotherapy for urological cancers. Jpn. J. Urol. 1990; 81: 251-7.
19. Shipley WU, Verhey LJ, Munzenrider JE et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Radiat. Oncol. Biol. Phys. 1995; 32: 3-12.
20. Noguchi R, Miyanaga N, Ishikawa H et al. Intra-artcrial chemotherapy for bladder cancer by insertion of catheter from inferior gluteal artery. Urol. Int. 1991; 47 (Suppl.): 113-15.
21. Sarkis AS, Bajorin DF, Reuter VE et al. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J. Clin. Oncol. 1995; 13: 1384-90.